[ad_1]
Operational indicators of the COVID-19 pandemic for the last day:
Number of new human cases detected in the last day: 491
Of which confirmed by laboratory diagnostic methods: 486
Total number of cases detected in specific individuals: 186,770
Of which confirmed by laboratory diagnostic methods: 183496
People who died in Covid-19 on the last day preliminary* number 10
* The number of deaths in the last day is preliminary and increases by around 20-40% in a few days.
The deaths from Covid-19 were recorded the day before with an actual date of:
There has been an increase in deaths from Covid-19 during the last day (10 + 0): 10
Total number of deaths from Covid-19: 2,937
Number of people recovered in the last day: 78
Number of people who recovered: 138 108
Number of people with coronavirus: 43,364
Samples of suspected coronavirus analyzed during the previous day: 3803
To date, a total of samples have been analyzed for suspected coronavirus: 1978848
Last day of vaccination with the first dose: 95
Second dose of vaccine vaccinated the day before: 649
Total vaccinated with the first dose: 78552
Total vaccinated with the first dose: 78552
Total pending for the second dose of the vaccine (78552-45336): 33216
Total number of vaccines used (78552 + 45336): 123888
Yesterday, Statistics Lithuania reported 676 new cases of coronavirus disease and another 15 deaths.
Yesterday, the leader of the Liberal Movement, president of the Seimas Viktorija Čmilytė-Nielsen, stated that after evaluating the morbidity indicators, the quarantine conditions could be relaxed in the near future in Rietavas, Jurbarkas district, Kalvarija and Birštonas municipalities. Here, according to her, some service providers and businesses could be opened.
On Saturday night, the Ministry of Health (SAM) shared the good news – the first shipment of vaccines from the pharmaceutical company AstraZeneca – 12 thousand – was delivered to the warehouse of the Health Emergencies Center. vaccine dose. According to the ministry, a coronavirus vaccine developed by a British and Swedish company will be administered to people under the age of 55 for now, but the final decision on the age limit will be made later.
[ad_2]
